Companies: 10,795·Total market cap: $144.5T
I-Mab

I-Mab

IMABNASDAQHealthcare
$2.88
$-0.02(-0.69%)
Market Cap$542009454
P/E Ratio
52W High$6.79
52W Low$0.595
Overview

I-Mab (IMAB) Revenue

Annual & quarterly revenue history · segment & region breakdown

IMAB · revenue · updated Jun 8, 2026

Core revenue metrics

I-Mab trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2024.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
-100.00%
vs FY2024 $0.00B
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
32 employees
FY2024
$0.00B
FY2023
$0.00B
5Y CAGR
+-100.0%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · I-Mab SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20242017 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2024-12-31$0.00B-$0.00B-100.00%
2023-12-31$0.00B+$0.02B
2022-12-31$-0.01B-$0.10B-112.15%
2021-12-31$0.09B-$1.45B-94.29%
2020-12-31$1.54B+$1.51B+5042.23%
2019-12-31$0.03B-$0.02B-44.22%
2018-12-31$0.05B+$0.04B+365.39%
2017-12-31$0.01B
IMAB revenue by year · IMAB revenue history · IMAB annual revenue data

Revenue breakdown

Segment & Geography
By business segment
Total$0.03B
$0.02B60.8%
$0.01B39.2%
By geography
No segment data available for this period.
Data from I-Mab annual 10-K filing · FY ending 2023-12-31
IMAB revenue breakdown · IMAB revenue by segment · IMAB revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income I-Mab receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

I-Mab reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from I-Mab's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

IMAB revenue · 4 questions

IMAB's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2024.

IMAB revenueIMAB annual revenuewhat is IMAB revenueIMAB TTM revenue

Source: FMP · I-Mab SEC filings · GAAP · I-Mab SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026